legal statement

Legal statement

No Warranty or Liability:
While Microlin Bio is making great efforts to include accurate and up-to-date information, we make no representations or warranties, express or implied, as to the accuracy or completeness of the information provided on this Website and disclaim any liability for the use of this site or any site linked to it. Microlin Bio may change this site at any time without notice but does not assume any responsibility to update it. All users agree that all access and use of this Website and any Website linked to from this site and the content thereof is at their own risk. Neither Microlin Bio nor any other party involved in creating, producing or delivering this Website or on any Website linked to from this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Website or any Website linked to from this site, or any errors or omissions in the content thereof.

Forward-looking Statements:
Statements made in this website that state our intentions, strategy, hopes, beliefs, expectations or predictions of the future are forward-looking statements. It is important to note that future events and actual results, financial or otherwise, could differ materially from those projected in such forward-looking statements. These forward looking statements include, but are not limited to, statements about: (i) the initiation, cost, timing, progress and results of our pre-clinical research and development activities; (ii) our compliance with the terms of our in-license agreements, including our exclusive in-license agreements with Ohio State Innovation Foundation; (iii) our ability to generate revenue; (iv) our ability to obtain additional financing; (v) our use of the net proceeds of this offering; (vi) our ability to continue as a going concern; (vii) our ability to obtain or maintain the rights to microRNA intellectual property and to successfully enforce our intellectual property rights; (viii) the safety, efficacy and market acceptance of microRNA technology and our other product candidates; (ix) validation of our clinical diagnostics; (x) regulatory approval of our product candidates and future product candidates we may develop, and the labeling under any approval we may obtain; (xi) our ability to obtain orphan drug designation for Lumiralin and Omiralin, two of our product candidates; (xii) future regulation of clinical laboratory tests by the FDA; (xiv) our ability to bring our product candidates to clinical trial; (xv) regulatory developments; (xvi) the development, success or failure of competing drugs that are or become available; (xvii) the potential markets for our product candidates and our ability to serve and compete in those markets; (xviii) our ability to build and maintain strategic partnerships; (xix) our compliance with environmental, health and safety laws and regulations such as federal and state healthcare fraud and abuse laws and regulations; (xx) our ability to successfully defend any product liability claims; (xxi) the performance of our third party partners, including third party manufacturers and suppliers; (xxii) our ability to obtain reimbursement coverage by third party payors for our product candidates; (xxiii) our ability to obtain formulary approval; (xxiv) the production of our product candidates within a viable cost structure; (xxv) our ability to recruit and maintain key scientific, management personnel, board members or employees; (xxvi) successful development of our sales and marketing capabilities; (xxvii) the occurrence of system failures, natural or man-made disasters or terrorist attacks disrupting our ability to operate; (xxviii) our ability to establish and maintain effective disclosure controls and procedures; and (xxix) the accuracy of our estimates regarding expenses, future revenues, capital requirements and need for additional financing. These forward-looking statements are only predictions and we may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements. You should not place undue reliance on our forward-looking statements.

No Offer or Solicitation:
The information provided on this Website does not constitute an offer of or solicitation for the purchase or disposal of, trading or any transaction in any Microlin Bio securities. Investors must not rely on this information for investment decisions.

Trademarks:
The Microlin Bio name and logo are trademarks owned or used by Microlin Bio, Inc.

Copyright:
The Website of Microlin Bio and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission or other use is strictly prohibited. Request for permission to reproduce any information contained on this Website should be addressed to Microlin Bio at info@microlinbio.com.

Links:
Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.